Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06452849

Amygdala and dLPFC MRI-TIS for Depression in Adolescents

Temporal Interference Stimulation of Amygdala and dLPFC: A Randomized Controlled Trial for Adolescent Depression

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University · Academic / Other
Sex
All
Age
14 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The study utilizes a non-invasive deep brain stimulation (temporal interference, TI) technique primarily targeting the amygdala to preliminarily explore the clinical efficacy and potential mechanisms of MRI-compatible TI technology in regulating the amygdala in adolescent depressive disorders.

Conditions

Interventions

TypeNameDescription
DEVICENervio-XAn 8-channel TIS device developed by NEURODOME Corporation.

Timeline

Start date
2024-05-27
Primary completion
2025-04-28
Completion
2025-04-28
First posted
2024-06-11
Last updated
2024-06-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06452849. Inclusion in this directory is not an endorsement.

Amygdala and dLPFC MRI-TIS for Depression in Adolescents (NCT06452849) · Clinical Trials Directory